Talk:Novozymes
From Wikipedia, the free encyclopedia
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||
Rename article to Novonesis?
Should the article be renamed to Novonesis, or should a new article for Novonesis be created?
There were two attempts to create the Novonesis article which failed for various reasons, but I've now just submitted a third draft for review. In the draft I call Novonesis as its legal name Novozymes A/S (dba Novonesis). I'm of the opinion that there's enough difference between the original Novozymes and Novonesis/Novozymes, it makes sense to keep them apart and should the draft be accepted use Template:About to link between the two.
Thinking of M&As I know of, I think with DSM-Firmenich both DSM (company) and Firmenich still exist as distinct articles, as do Ahold and Delhaize Group for Ahold Delhaize.
However, if there's a rule for M&As like this then I will follow the procedure established for that. netstars22 (talk) 01:35, 5 February 2026 (UTC)
Guidance requested - 04-02-2014
Dear Wikipedia Editors,
My name is Fred at Novozymes, and, as per my user page, I have established an account in order to help further develop Novozymes’ article on Wikipedia – in line with Wikipedia standards and guidelines.
The Novozymes article is currently tagged. As such, I would like to offer my support to further develop the article so that it is in line with Wikipedia’s standards and guidelines. At this stage, I have reached out to Pdcook, who originally tagged the Novozymes article, asking for a bit of guidance as for how the community, including myself, can help bring the article in compliance. I have currently awaited an answer for more than 48 hours, which is why I have decided to reach out to the broader editor community instead.
 | This help request has been answered. If you need more help, you can , contact the responding user(s) directly on their user talk page, or consider visiting the Teahouse. |
Could I kindly ask editors to provide a bit of guidance as for how the Novozymes article can be further developed so that it is in line with Wikipedia standards and guidelines?
With many thanks, and kind regards,
Fred at Novozymes (talk) 13:43, 4 February 2014 (UTC)
- Thanks for being upfront about your affiliation with the subject. First and foremost, I'd recommend you read the information at Conflict of interest and Best practice for COI editors, which will help you avoid coming into conflict with Wikipedia over the article's content.
- As far as sprucing up the article is concerned, there are a couple of key areas to address. Firstly, the sourcing is very weak. Wikipedia prefers secondary, independent sources to primary ones, and requires in-depth coverage in those sources. If you can verify some of the material on the page by citing newspapers, magazines, books or reliable, unaffiliated websites, that would be a substantial improvement. See this essay for a basic outline of how to format citations.
- Secondly, the content needs expansion; areas you could consider might include business practices, major competitors, any well-reported controversies, business model, locations, stock valuation and directors/executives (especially if they are notable in their own right). See Wikipedia:WikiProject Companies/Guidelines for more ideas. As will all Wikipedia content, anything you add will need to be sourced.
- Most importantly, bear in mind that this is not a page for you to tell the world about your company; it is an article designed to aggregate existing information that would be of interest to a reader of the encyclopedia. If a fact about the company hasn't been published somewhere else, it doesn't belong here.
- I hope this is helpful. Yunshui 雲水 14:21, 4 February 2014 (UTC)
Lead section edit requested - 28-04-2014
 | Part of an edit requested by an editor with a conflict of interest has been implemented. most was good, left some promotional stuff out, and found additional sources |
As per various correspondences with Matticusmadness and Yunshui, I am hereby suggesting a new lead section to ensure this article will move into compliance with Wikipedia standards and guidelines.
As per my user page, my account was established in order to help further develop Novozymes’ articles on Wikipedia – in line with Wikipedia standards and guidelines.
With many thanks, and kind regards,
Fred at Novozymes (talk) 23:48, 27 April 2014 (UTC)
---Lead section suggestion starts---
Novozymes is a global biotechnology company headquartered in Bagsværd outside of Copenhagen, Denmark employing approximately 6,300 people by the end of 2013. The company has operations in a number of countries around the world, including China, India, Brazil, Argentina, England, the United States, and Canada.
The company’s focus is the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. As of 2013, the company holds an estimated 48% of the global enzyme market, making it the world’s largest producer of industrial enzymes.[1][2]
Novozymes was founded in 2000 in a demerger from pharmaceutical company Novo Nordisk, although its roots date back to the 1920s when Novo Terapeutisk Laboratorium and Nordisk Insulinlaboratorium were established in Copenhagen.[3] Its B shares are listed on the NASDAQ OMX Nordic.[4]
The company itself labels its core work as “bioinnovation”, with the intention to use biotechnology to develop more sustainable solutions towards industries such as agriculture, bioenergy, household care, textiles, and the pharmaceutical industry. In January 2014, Novozymes was ranked the most sustainable company in the biotechnology sector in The Sustainability Yearbook 2014 for the fifth year in a row.[5] In 2009, Forbes included Novozymes as one of 100 corporations that will survive 100 years.[6] In 2012, Novozymes was placed fourth in Corporate Knights’ Global 100 ranking of the world’s most sustainable corporations.[7]
Novozymes is a partner of and a supplier to companies such as Procter & Gamble, which in 2013 awarded Novozymes their Business Partner of the Year for the sixth time, and Henkel, which in 2013 awarded Novozymes the Henkel Innovation Award.[8][9] Other partners and customers include Unilever, Cargill, Beta Renewables, and Archer Daniels Midland.
